Press Releases

SOUTH SAN FRANCISCO, Calif., July 9, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the promotions of Paul A. Stone, J.D., as Chief Financial Officer, Andre

FRISCO, Texas, July 9, 2019 /PRNewswire/ -- Argon Medical Devices, Inc., a leading global manufacturer of specialty medical devices used in interventional procedures, announced today that it has entered into a definitive license agreement with Hatch Medical, L.L.C. ("Hatch Medical") for exclusive global rights to market and distribute the Scorpion™ TIPS Acces

LOS ANGELES, July 9, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreement, Roche will use ImaginAb's novel minibody CD8 T cell imaging agent in immuno-oncology clinical trials for multiple types o

CLEVELAND, July 9, 2019 /PRNewswire/ -- Vanderbilt-Ingram Cancer Center and GenomOncology LLC announce the launch of the newly redesigned and improved My Cancer Genome website. The new site showcases the breadth and depth of curated content from My Cancer Genome.

MUMBAI, India, July 9, 2019 /PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OECD-Good Laboratory Practice (GLP) certificat

STOCKHOLM, July 9, 2019 /PRNewswire/ -- Clinical study data on switching haemophilia A and B patients from on-demand treatment to extended half-life (EHL) prophylaxis showed a positive impact on clinical outcomes, with improvements in quality of life (QoL) and reduced annual bleeding rates (ABR). The results of these joint studies by

RIDGEFIELD, Conn., July 8, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced results from two pediatric studies of Pradaxa®, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.

RANCHO CUCAMONGA, Calif., July 8, 2019 /PRNewswire/ -- The Governing Board of Inland Empire Health Plan (IEHP) has announced that IEHP Chief Operating Officer Jarrod B. McNaughton will succeed Dr. Bradley P. Gilbert as Chief Executive Officer, effective July 20, 2019.

AUSTIN, Texas, July 8, 2019 /PRNewswire/ -- Direct Biologics, LLC announces the launch of ExoFloTM Exosomes. The mission of Direct Biologics is to deliver di

AUSTIN, Texas, July 8, 2019 /PRNewswire/ -- Direct Biologics, LLC announces the launch of ExoFloTM Exosomes. The mission of Direct Biologics is to deliver di